Anemia

• 

  Subject Areas on Research

  • 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) induces peripheral blood abnormalities and plasma cell neoplasms resembling multiple myeloma in mice. 
  • 2002 E. Mead Johnson Award for Research in Pediatrics Lecture: the molecular biology of the anemia of chronic disease: a hypothesis. 
  • A 79-Year-Old Female Patient With Altered Mental Status and Anemia. 
  • A descriptive evaluation of transfusion practices in patients receiving mechanical ventilation. 
  • A missense mutation in TFRC, encoding transferrin receptor 1, causes combined immunodeficiency. 
  • A mouse model of adult-onset anaemia due to erythropoietin deficiency. 
  • A multi-center phase II study of weekly topotecan as second-line therapy for small cell lung cancer. 
  • A multi-institutional evaluation of factors predictive of toxicity and efficacy of bevacizumab for recurrent ovarian cancer. 
  • A mutation in Sec15l1 causes anemia in hemoglobin deficit (hbd) mice. 
  • A new NOS2 promoter polymorphism associated with increased nitric oxide production and protection from severe malaria in Tanzanian and Kenyan children. 
  • A phase 1 trial of SGN-CD70A in patients with CD70-positive, metastatic renal cell carcinoma. 
  • A phase II study of farnesyl transferase inhibitor R115777 in pancreatic cancer: a Southwest oncology group (SWOG 9924) study. 
  • A phase II trial of O6-benzylguanine and carmustine in patients with advanced soft tissue sarcoma. 
  • A phase IIA randomized clinical trial of a multiclade HIV-1 DNA prime followed by a multiclade rAd5 HIV-1 vaccine boost in healthy adults (HVTN204). 
  • A prospective randomized wait list control trial of intravenous iron sucrose in older adults with unexplained anemia and serum ferritin 20-200 ng/mL. 
  • A prospective study of outcomes of nursing home residents with chronic kidney disease with and without anemia. 
  • A quick scoping review of efficacy, safety, economic, and health-related quality-of-life outcomes of short- and long-acting erythropoiesis-stimulating agents in the treatment of chemotherapy-induced anemia and chronic kidney disease anemia. 
  • A randomized trial comparing immediate versus delayed treatment of anemia with once-weekly epoetin alfa in patients with non-small cell lung cancer scheduled to receive first-line chemotherapy. 
  • A reduced transferrin saturation is independently associated with excess morbidity and mortality in older adults with heart failure and incident anemia. 
  • A secondary analysis of the CHOIR trial shows that comorbid conditions differentially affect outcomes during anemia treatment. 
  • Absolute lymphocyte count is a prognostic marker in Covid-19: A retrospective cohort review. 
  • Activity level, apoptosis, and development of cachexia in Apc(Min/+) mice. 
  • Acute coronary syndromes: Blood transfusion in patients with acute MI and anaemia. 
  • Acute renal injury and lowest hematocrit during cardiopulmonary bypass: not only a matter of cellular hypoxemia. 
  • Addressing the unmet need of life-threatening anemia with hemoglobin-based oxygen carriers. 
  • Adjunctive agents in systemic chemotherapy. 
  • Adolescent Infertility: A Case Report. 
  • Age and alarm symptoms do not predict endoscopic findings among patients with dyspepsia: a multicentre database study. 
  • Aggravation of exercise performance in patients with anemia by 3% carboxyhemoglobin. 
  • Alopecia in IL-10-deficient mouse pups is c-kit-dependent and can be triggered by iron deficiency. 
  • American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer. 
  • American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer. 
  • An international cohort study of autosomal dominant tubulointerstitial kidney disease due to REN mutations identifies distinct clinical subtypes. 
  • Anaemia and coronary artery disease severity in patients with heart failure. 
  • Anaemia of CKD--the CHOIR study revisited. 
  • Anaemia prevention in the community: students as change agents. 
  • Analysis of complication rates following perioperative transfusion in shoulder arthroplasty. 
  • Anemia and Functional Disability in Older Adults With Cancer. 
  • Anemia and associated clinical outcomes in patients with heart failure due to reduced left ventricular systolic function. 
  • Anemia and blood transfusion in trauma patients admitted to the intensive care unit. 
  • Anemia and cancer in older persons. 
  • Anemia and hemoglobin levels in older persons: relationship with age, gender, and health status. 
  • Anemia and its impact on function in nursing home residents: what do we know? 
  • Anemia and lung cancer. 
  • Anemia as a risk factor and therapeutic target in heart failure. 
  • Anemia evaluation and management in nursing home residents. 
  • Anemia in patients with heart failure and preserved systolic function. 
  • Anemia in the elderly: clinical impact and practical diagnosis. 
  • Anemia is associated with bleeding and mortality, but not stroke, in patients with atrial fibrillation: Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial. 
  • Anemia is associated with decreased survival and increased locoregional failure in patients with locally advanced head and neck carcinoma: a secondary analysis of RTOG 85-27. 
  • Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12 065 patients with new-onset heart failure. 
  • Anemia of inflammation: the cytokine-hepcidin link. 
  • Anemia of inflammation: the hepcidin link. 
  • Anemia prevalence in women of reproductive age in low- and middle-income countries between 2000 and 2018. 
  • Are there clinical benefits with early erythropoietic intervention for chemotherapy-induced anemia? A systematic review. 
  • Arginine, nitric oxide, carbon monoxide, and endothelial function in severe malaria. 
  • Assessment of primary hemostasis by PFA-100 analysis in a tertiary care center. 
  • Association Between Atopic Disease and Anemia in US Children. 
  • Association between bone marrow dosimetric parameters and acute hematologic toxicity in anal cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy. 
  • Association between hemoglobin level and cardiopulmonary performance in heart failure: insights from the HF-ACTION study. 
  • Association between peripheral blood cytopenia and cancer mortality: A race-specific risk factor for cancer death. 
  • Association of Anemia with Venous Thromboembolism in Acutely Ill Hospitalized Patients: An APEX Trial Substudy. 
  • Association of Testosterone Levels With Anemia in Older Men: A Controlled Clinical Trial. 
  • Association of anemia and long-term survival in patients with pulmonary hypertension. 
  • Association of anemia and physical disability among patients with rheumatoid arthritis. 
  • Association of preoperative anaemia with cardiopulmonary exercise capacity and postoperative outcomes in noncardiac surgery: a substudy of the Measurement of Exercise Tolerance before Surgery (METS) Study. 
  • Association of serum phosphorus level with anemia in kidney transplant recipients. 
  • Associations between hemoglobin level, resource use, and medical costs in patients with heart failure: findings from HF-ACTION. 
  • Baseline characteristics of patients in the Reduction of Events with Darbepoetin alfa in Heart Failure trial (RED-HF). 
  • Benefits and risks of using erythropoiesis-stimulating agents (ESAs) in lung cancer patients: study-level and patient-level meta-analyses. 
  • Benefits of early intervention with erythropoiesis- stimulating proteins in chemotherapy-induced anemia. 
  • Biomarkers in the management and treatment of men with metastatic castration-resistant prostate cancer. 
  • Biomarkers of erythropoiesis response to intravenous iron in a crossover pilot study in unexplained anemia of the elderly. 
  • Blood Products in the Management of Abnormal Placentation. 
  • Blood Substitutes and Oxygen Therapeutics: A Review. 
  • Blood transfusion after percutaneous coronary intervention and risk of subsequent adverse outcomes: a systematic review and meta-analysis. 
  • Blood transfusion during acute myocardial infarction: association with mortality and variability across hospitals. 
  • Blood transfusions, thrombosis, and mortality in hospitalized patients with cancer. 
  • Blood utilization and hemoglobin levels in cancer patients after label and coverage changes for erythropoiesis-stimulating agents. 
  • Boceprevir for untreated chronic HCV genotype 1 infection. 
  • Bone marrow enhancement during time-resolved magnetic resonance angiography of the pelvis. 
  • Cancer- and chemotherapy-induced anemia. 
  • Cancer- and chemotherapy-induced anemia. 
  • Cancer- and treatment-related anemia. 
  • Cancer-related fatigue. 
  • Cardiovascular toxicity of epoetin-alfa in patients with chronic kidney disease. 
  • Care of the patient with cardiovascular disease undergoing general surgery. 
  • Cerebral Oxygenation and Transfusion for Severe Anemia: Searching for Functional Outcomes to Guide Transfusion. 
  • Characterization and pathogenesis of anemia in glycogen storage disease type Ia and Ib. 
  • Chronic renal failure in infants and children. 
  • Clinical Impact of Routine Complete Blood Counts Following Total Knee Arthroplasty. 
  • Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure: results of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Program. 
  • Clinical profile and prognostic value of anemia at the time of admission and discharge among patients hospitalized for heart failure with reduced ejection fraction: findings from the EVEREST trial. 
  • Clinical trials evaluating red blood cell transfusion thresholds: An updated systematic review and with additional focus on patients with cardiovascular disease. 
  • Clinico-pathologic conference: 12-year-old girl with fatigue, anemia, weight loss, abdominal distention, and occasional nausea and vomiting. 
  • Cloning of a cDNA encoding bovine erythropoietin and analysis of its transcription in selected tissues. 
  • Colorectal cancer. 
  • Commentaries on Viewpoint: Anemia contributes to cardiovascular disease through reductions in nitric oxide. 
  • Common Medical Comorbidities Correlated With Poor Outcomes in Hip Periprosthetic Infection. 
  • Comorbidities in Heart Failure: Are There Gender Differences? 
  • Comparative outcomes of predominant facility-level use of ferumoxytol versus other intravenous iron formulations in incident hemodialysis patients. 
  • Complexity of the msp2 locus and the severity of childhood malaria, in south-western Nigeria. 
  • Connect MM Registry: The Importance of Establishing Baseline Disease Characteristics. 
  • Controversies in optimal anemia management: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference. 
  • Coronary Thrombosis and Major Bleeding After PCI With Drug-Eluting Stents: Risk Scores From PARIS. 
  • Correction of anemia with epoetin alfa in chronic kidney disease. 
  • Cost effectiveness, quality-adjusted life-years and supportive care. Recombinant human erythropoietin as a treatment of cancer-associated anaemia. 
  • Cutaneous granulomas in children with combined immunodeficiency. 
  • Daprodustat and On-Treatment Cardiovascular Events in Chronic Kidney Disease. Reply. 
  • Daprodustat for the Treatment of Anemia in Patients Not Undergoing Dialysis. 
  • Daprodustat for the Treatment of Anemia in Patients Undergoing Dialysis. 
  • Deficiency of Adenosine Deaminase 2 in Adults and Children: Experience From India. 
  • Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk. 
  • Definition and management of anemia in patients infected with hepatitis C virus. 
  • Design of the Reduction of Events with Darbepoetin alfa in Heart Failure (RED-HF): a Phase III, anaemia correction, morbidity-mortality trial. 
  • Detection of iron deficiency in children with Down syndrome. 
  • Development of a Metastatic Spinal Tumor Frailty Index (MSTFI) Using a Nationwide Database and Its Association with Inpatient Morbidity, Mortality, and Length of Stay After Spine Surgery. 
  • Developmental allometry and paediatric malaria. 
  • Diabetes mellitus and advanced liver fibrosis are risk factors for severe anaemia during telaprevir-based triple therapy. 
  • Diagnostic and Therapeutic Yield of Endoscopy in Patients with Elevated INR and Gastrointestinal Bleeding. 
  • Diagnostic blood loss from phlebotomy and hospital-acquired anemia during acute myocardial infarction. 
  • Differences in bleeding phenotype and provider interventions in postmenarchal adolescents when compared to adult women with bleeding disorders and heavy menstrual bleeding. 
  • Differentiating thrombotic microangiopathies induced by severe hypertension from anemia and thrombocytopenia seen in thrombotic thrombocytopenia purpura. 
  • Does review of peripheral blood smears help in the initial workup of common anemias? 
  • Dose intensity and hematologic toxicity in older breast cancer patients receiving systemic chemotherapy. 
  • Double jeopardy of renal insufficiency and anemia in patients undergoing percutaneous coronary interventions. 
  • Dual Diagnosis and Total Hip Arthroplasty. 
  • Early hemoglobin response and alternative metrics of efficacy with erythropoietic agents for chemotherapy-related anemia. 
  • Economic evaluation of weekly epoetin alfa versus biweekly darbepoetin alfa for chemotherapy-induced anaemia: evidence from a 16-week randomised trial. 
  • Effect of hemoglobin target on progression of kidney disease: a secondary analysis of the CHOIR (Correction of Hemoglobin and Outcomes in Renal Insufficiency) trial. 
  • Effect of maternal anemia at high altitude on infant hematocrit and oxygenation. 
  • Effects of anemia and hypotension on porcine optic nerve blood flow and oxygen delivery. 
  • Efficacy and Safety of Daprodustat for Treatment of Anemia of Chronic Kidney Disease in Incident Dialysis Patients: A Randomized Clinical Trial. 
  • Elevated nitric oxide production in children with malarial anemia: hemozoin-induced nitric oxide synthase type 2 transcripts and nitric oxide in blood mononuclear cells. 
  • Epoetin treatment of anemia associated with cancer therapy: a systematic review and meta-analysis of controlled clinical trials. 
  • Erythrocyte anisocytosis. Visual inspection of blood films vs automated analysis of red blood cell distribution width. 
  • Erythropoiesis-stimulating agents in cancer. 
  • Erythropoiesis-stimulating agents in oncology: a study-level meta-analysis of survival and other safety outcomes. 
  • Erythropoiesis-stimulating agents increase the risk of acute stroke in patients with chronic kidney disease. 
  • Erythropoiesis-stimulating protein support and survival. 
  • Erythropoietic response to anemia in chronic hepatitis C patients receiving combination pegylated interferon/ribavirin. 
  • Erythropoietin for oncology supportive care. 
  • Erythropoietin: high profile, high scrutiny. 
  • Establishing the Cause of Anemia in a Premature Newborn Infant. 
  • Estimation of Achievable Oxygen Consumption Following Transfusion With Rejuvenated Red Blood Cells. 
  • Evaluating anemia in children. 
  • Evaluation of Peruvian Government Interventions to Reduce Childhood Anemia. 
  • Extended epoetin alfa dosing as maintenance treatment for the anemia of chronic kidney disease: the PROMPT study. 
  • Failure of red blood cell maturation in mice with defects in the high-density lipoprotein receptor SR-BI. 
  • Fatigue in children and adolescents with cancer: evolution of a program of study. 
  • Fibroblast Growth Factor 23 and Anemia in the Chronic Renal Insufficiency Cohort Study. 
  • Further aspects of anemia, heart failure, and erythropoietin. 
  • Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. 
  • HIF stabilization by prolyl hydroxylase inhibitors for the treatment of anemia in chronic kidney disease. 
  • Hematologic findings in a large sample of patients with anorexia nervosa and bulimia nervosa. 
  • Heme oxygenase 1 is required for mammalian iron reutilization. 
  • Hemoglobin response and improvements in quality of life in anemic children with cancer receiving myelosuppressive chemotherapy. 
  • Hemoglobin, exercise training, and health status in patients with chronic heart failure (from the HF-ACTION randomized controlled trial). 
  • Hemopoiesis and aging. 
  • High prevalence of malaria parasitemia and anemia among hospitalized children in Rakai, Uganda. 
  • High-dose IV iron for anemia correction in chronic kidney disease. 
  • High-dose doxorubicin, dexrazoxane, and GM-CSF in malignant mesothelioma: a phase II study-Cancer and Leukemia Group B 9631. 
  • Higher hemoglobin levels and quality of life in patients with advanced chronic kidney disease: no longer a moving target? 
  • Higher or Lower Hemoglobin Transfusion Thresholds for Preterm Infants. 
  • Hospital-acquired anemia and in-hospital mortality in patients with acute myocardial infarction. 
  • How do we develop and implement a preoperative anemia clinic designed to improve perioperative outcomes and reduce cost? 
  • Human-Centered Design of a Clinical Decision Support for Anemia Screening in Children with Inflammatory Bowel Disease. 
  • Hypoxia Signaling Cascade for Erythropoietin Production in Hepatocytes. 
  • Hypoxia and anemia: factors in decreased sensitivity to radiation therapy and chemotherapy? 
  • ITPA gene polymorphisms significantly affect hemoglobin decline and treatment outcomes in patients coinfected with HIV and HCV. 
  • Immuno-virologic outcomes and immuno-virologic discordance among adults alive and on anti-retroviral therapy at 12 months in Nigeria. 
  • Impact of Anemia on Platelet Reactivity and Ischemic and Bleeding Risk: From the Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents Study. 
  • Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: analysis from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial. 
  • Impact of anemia on physical function and survival among patients with coronary artery disease. 
  • Impact of anemia on surgical outcomes: innovative interventions in resource-poor settings. 
  • Impact of intermittent screening and treatment for malaria among school children in Kenya: a cluster randomised trial. 
  • Implementation of a Preoperative Anemia Clinic Utilizing a Minimal Staffing Model. 
  • Incidence and severity of acute complications after spinal cord injury. 
  • Incidence of anemia in children with solid tumors or Hodgkin disease. 
  • Incidence, correlates, and outcomes of acute, hospital-acquired anemia in patients with acute myocardial infarction. 
  • Incident anaemia in older adults with heart failure: rate, aetiology, and association with outcomes. 
  • Influence of Baseline Anemia on Dual Antiplatelet Therapy Cessation and Risk of Adverse Events After Percutaneous Coronary Intervention. 
  • Inhibition of HIF prolyl-hydroxylase domain to correct anemia in patients with chronic kidney disease. 
  • Inosine triphosphatase deficiency helps predict anaemia, anaemia management and response in chronic hepatitis C therapy. 
  • Inosine triphosphatase genetic variants are protective against anemia during antiviral therapy for HCV2/3 but do not decrease dose reductions of RBV or increase SVR. 
  • Intensity-modulated radiation therapy for anal malignancies: a preliminary toxicity and disease outcomes analysis. 
  • Intravenous iron administration strategies and anemia management in hemodialysis patients. 
  • Is the RDW-MCV classification of anaemia useful? 
  • Is weekly iron and folic acid supplementation as effective as daily supplementation for decreasing incidence of anemia in adolescent girls? 
  • Ischemic Retinal Vascular Disease in an Infant With Hemophagocytic Lymphohistiocytosis. 
  • Isn't it about time we learned how to use blood transfusion in patients with ischemic heart disease? 
  • Lack of Association Between Anemia and Intrinsic Left Ventricular Diastolic Function or Cardiac Mechanics in Heart Failure With Preserved Ejection Fraction. 
  • Laparoscopic surgical treatment for refractory gastric antral vascular ectasia: a case report and review. 
  • Late-stage tumors induce anemia and immunosuppressive extramedullary erythroid progenitor cells. 
  • Longer-term outcomes of darbepoetin alfa versus epoetin alfa in patients with ESRD initiating hemodialysis: a quasi-experimental cohort study. 
  • Longitudinal analysis of T-cell receptor variable beta chain repertoire in patients with acute graft-versus-host disease after allogeneic stem cell transplantation. 
  • Low hemoglobin levels and recurrent falls in U.S. men and women: prospective findings from the REasons for Geographic And Racial Differences in Stroke (REGARDS) cohort. 
  • Lower hemoglobin concentration decreases time to death in severely anemic patients for whom blood transfusion is not an option. 
  • Maintenance Sunitinib following Initial Platinum-Based Combination Chemotherapy in Advanced-Stage IIIB/IV Non-Small Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III Study-CALGB 30607 (Alliance). 
  • Management of anemia in children receiving chronic peritoneal dialysis. 
  • Managing cancer-related anaemia in congruence with the EORTC guidelines is an independent predictor of haemoglobin outcome: initial evidence from the RESPOND study. 
  • Marginal structural models for analyzing causal effects of time-dependent treatments: an application in perinatal epidemiology. 
  • Menorrhagia in patients with type I glycogen storage disease. 
  • Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene. 
  • Microcytic anemia in mk/mk mice is not corrected by retroviral-mediated gene transfer of wild-type p45 NF-E2. 
  • Mitochondrial myopathy with anemia, cardiomyopathy, and lactic acidosis: a distinct late onset mitochondrial disorder. 
  • Modeling of treatment response to erythropoiesis-stimulating agents as a function of center- and patient-related variables: results from the Anemia Cancer Treatment (ACT) study. 
  • Mouse microcytic anaemia caused by a defect in the gene encoding the globin enhancer-binding protein NF-E2. 
  • Multinational, double-blind, phase III study of prednisone and either satraplatin or placebo in patients with castrate-refractory prostate cancer progressing after prior chemotherapy: the SPARC trial. 
  • Myelodysplastic Syndromes, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. 
  • Myelodysplastic syndromes in the United States: an update for clinicians. 
  • Myelodysplastic syndromes. 
  • Myelodysplastic syndromes: clinical practice guidelines in oncology. 
  • Myelotoxicity from chemotherapy. 
  • NCCN practice guidelines for the myelodysplastic syndromes. National Comprehensive Cancer Network. 
  • Neuropsychological dysfunction and neuroimaging abnormalities in neurologically intact adults with sickle cell anemia. 
  • Nitric oxide, malaria, and anemia: inverse relationship between nitric oxide production and hemoglobin concentration in asymptomatic, malaria-exposed children. 
  • Noncardiac comorbidities and acute heart failure patients. 
  • Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction. 
  • Nonimmune hydrops and hydrocephalus secondary to fetal intracranial hemorrhage. 
  • Normalization of hematocrit in hemodialysis patients does not affect silent ischemia. 
  • Normalization of hematocrit in hemodialysis patients with cardiac disease does not increase blood pressure. 
  • Novel marine-derived anticancer agents: a phase I clinical, pharmacological, and pharmacodynamic study of dolastatin 10 (NSC 376128) in patients with advanced solid tumors. 
  • Ocular manifestations of hematologic disorders. 
  • Of mice and men: the mice were right. 
  • Outcomes in Patients Undergoing Cardiac Surgery Who Decline Transfusion and Received Erythropoietin Compared to Patients Who Did Not: A Matched Cohort Study. 
  • Oxygen instead of Blood - Not in too sick or too low. 
  • Oxygenation of head and neck cancer: changes during radiotherapy and impact on treatment outcome. 
  • Pathophysiologic mechanisms of anemia of chronic disease. 
  • Patient Blood Management: Recommendations From the 2018 Frankfurt Consensus Conference. 
  • Patterns of phlebotomy blood loss and transfusions in extremely low birth weight infants. 
  • Perioperative Anemia and Transfusions and Late Mortality in Coronary Artery Bypass Patients. 
  • Perioperative Anemia: Prevention, Diagnosis, and Management Throughout the Spectrum of Perioperative Care. 
  • Perioperative Quality Initiative and Enhanced Recovery After Surgery-Cardiac Society Consensus Statement on the Management of Preoperative Anemia and Iron Deficiency in Adult Cardiac Surgery Patients. 
  • Phase I evaluation of zidovudine administered to infants exposed at birth to the human immunodeficiency virus. 
  • Phase II randomized study of dose-dense docetaxel and cisplatin every 2 weeks with pegfilgrastim and darbepoetin alfa with and without the chemoprotector BNP7787 in patients with advanced non-small cell lung cancer (CALGB 30303). 
  • Phase II study of (90)Y Ibritumomab tiuxetan (Zevalin) in patients with previously untreated marginal zone lymphoma. 
  • Physical function in men and women with cancer. Effects of anemia and conditioning. 
  • Plasmodium falciparum, anaemia and cognitive and educational performance among school children in an area of moderate malaria transmission: baseline results of a cluster randomized trial on the coast of Kenya. 
  • Plasticity of renal erythropoietin-producing cells governs fibrosis. 
  • Polymerized bovine hemoglobin solution as a replacement for allogeneic red blood cell transfusion after cardiac surgery: results of a randomized, double-blind trial. 
  • Pooled analysis of individual patient-level data from all randomized, double-blind, placebo-controlled trials of darbepoetin alfa in the treatment of patients with chemotherapy-induced anemia. 
  • Posttransplant autoimmune hemolytic anemia and other autoimmune cytopenias are increased in very young infants undergoing unrelated donor umbilical cord blood transplantation. 
  • Pre- and postoperative anemia, acute kidney injury, and mortality after coronary artery bypass grafting surgery: a retrospective observational study. 
  • Predicting peripartum blood transfusion in women undergoing cesarean delivery: A risk prediction model. 
  • Predictors of Increased Length of Hospital Stay Following Laparoscopic Sleeve Gastrectomy from the National Surgical Quality Improvement Program. 
  • Predictors of consent to pharmacogenomics testing in the IDEAL study. 
  • Predictors of transfusion outcomes in pediatric complex cranial vault reconstruction: a multicentre observational study from the Pediatric Craniofacial Collaborative Group. 
  • Preference-based utility scores for adverse events associated with the treatment of gynecologic cancers. 
  • Preoperative Blood Management Strategy for Elective Hip and Knee Arthroplasty. 
  • Preoperative Hemoglobin Level is Associated with Increased Health Care Use After Elective Spinal Fusion (≥3 Levels) in Elderly Male Patients with Spine Deformity. 
  • Preoperative Hemoglobin Predicts Postoperative Transfusion Despite Antifibrinolytics During Total Knee Arthroplasty. 
  • Preoperative anemia predicts thrombosis and free flap failure in microvascular reconstruction. 
  • Pretreatment anemia is correlated with the reduced effectiveness of radiation and concurrent chemotherapy in advanced head and neck cancer. 
  • Prevalence and health correlates of anaemia among community-dwelling Chinese older adults: the China Health and Retirement Longitudinal Study. 
  • Prevention and diagnosis of delayed haemolytic transfusion reactions. 
  • Prognostic impact of blood transfusion after primary angioplasty for acute myocardial infarction: analysis from the CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) Trial. 
  • Prognostic significance of anaemia in patients with heart failure with preserved and reduced ejection fraction: results from the MAGGIC individual patient data meta-analysis. 
  • Proinflammatory, immunomodulating, and prothrombotic properties of anemia and red blood cell transfusions. 
  • Prospective assessment of the occurrence of anemia in patients with heart failure: results from the Study of Anemia in a Heart Failure Population (STAMINA-HFP) Registry. 
  • Quantification of the burden and consequences of pregnancy-associated malaria in the Democratic Republic of the Congo. 
  • Randomised clinical trial of ferric citrate hydrate on anaemia management in haemodialysis patients with hyperphosphataemia: ASTRIO study. 
  • Randomized double-blind trial of darbepoetin alfa in patients with symptomatic heart failure and anemia. 
  • Rationale and design for the myocardial ischemia and transfusion (MINT) randomized clinical trial. 
  • Recombinant human erythropoietin in cancer-related anemia. Review of clinical evidence. 
  • Recommendations From the International Consensus Conference on Anemia Management in Surgical Patients (ICCAMS). 
  • Recovery from hospital-acquired anemia after acute myocardial infarction and effect on outcomes. 
  • Red blood cell distribution width and 1-year mortality in acute heart failure. 
  • Red blood cell indices and development of hospital-acquired anemia during acute myocardial infarction. 
  • Redefining Unexplained Anemia in Elderly-Reply. 
  • Relation of Baseline Hemoglobin Levels and Adverse Events in Patients With Acute Coronary Syndromes (from the Acute Catheterization and Urgent Intervention Triage strategY and Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction Trials). 
  • Relation of anemia to diastolic heart failure and the effect on outcome. 
  • Relation of low hemoglobin and anemia to morbidity and mortality in patients hospitalized with heart failure (insight from the OPTIMIZE-HF registry). 
  • Relationship between anemia and health care costs in heart failure. 
  • Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy. 
  • Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. 
  • Renal Toxicity Associated with Salsalate in Elderly Adults with Anemia. 
  • Renal-failure anemia and nitrosourea therapy. 
  • Reply: To PMID 24266946. 
  • Resuscitation in hip fractures: a systematic review. 
  • Risk Factors for Heart Failure in Patients With Chronic Kidney Disease: The CRIC (Chronic Renal Insufficiency Cohort) Study. 
  • Ruptured popliteal artery aneurysm. 
  • S-nitrosylation therapy to improve oxygen delivery of banked blood. 
  • Safety and Efficacy of Ruxolitinib in Patients with Myelofibrosis and Low Platelet Counts (50 - 100 × 109/L): Final Analysis of an Open-Label Phase 2 Study. 
  • Safety and tolerability of the first-in-class agent CPI-613 in combination with modified FOLFIRINOX in patients with metastatic pancreatic cancer: a single-centre, open-label, dose-escalation, phase 1 trial. 
  • Safety of Intravenous Iron in Hemodialysis: Longer-term Comparisons of Iron Sucrose Versus Sodium Ferric Gluconate Complex. 
  • Safety of two-year caloric restriction in non-obese healthy individuals. 
  • Secondary analysis of the CHOIR trial epoetin-alpha dose and achieved hemoglobin outcomes. 
  • Severe anemia associated with increased risk of death and myocardial ischemia in patients declining blood transfusion. 
  • Some haematopathological features of marathon running. 
  • Sotatercept (ACE-011) for the treatment of chemotherapy-induced anemia in patients with metastatic breast cancer or advanced or metastatic solid tumors treated with platinum-based chemotherapeutic regimens: results from two phase 2 studies. 
  • Spatial and social factors drive anemia in Congolese women. 
  • Statistical and graphical evaluation of erythrocyte volume distributions. 
  • Study design and baseline characteristics of patients on dialysis in the ASCEND-D trial. 
  • Suppression of prostaglandin E2 by malaria parasite products and antipyretics promotes overproduction of tumor necrosis factor-alpha: association with the pathogenesis of childhood malarial anemia. 
  • Targeting anemia in patients with lung cancer. 
  • The ASCEND-ND trial: study design and participant characteristics. 
  • The CRIT Study: Anemia and blood transfusion in the critically ill--current clinical practice in the United States. 
  • The Nramp2/DMT1 iron transporter is induced in the duodenum of microcytic anemia mk mice but is not properly targeted to the intestinal brush border. 
  • The Pediatric Craniofacial Collaborative Group (PCCG) Consensus Conference Methodology. 
  • The Prospective Evaluation of the Net Effect of Red Blood Cell Transfusions in Routine Provision of Palliative Care. 
  • The association between intravenous iron for antenatal anemia and postnatal depression: a retrospective cohort study. 
  • The association between serum copper and anaemia in the adult Second National Health and Nutrition Examination Survey (NHANES II) population. 
  • The delivery of immunizations and other preventive services in private practices. 
  • The economic burden of anemia in cancer patients receiving chemotherapy. 
  • The effects of anemia on pregnancy outcome in patients with pyelonephritis. 
  • The effects of bedside blood gas monitoring on blood loss and ventilator management. 
  • The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries. 
  • The hematological effects of nitrous oxide anesthesia in pediatric patients. 
  • The impact of anaemia and its treatment on employee disability and medical costs. 
  • The impact of anemia on nursing home residents. 
  • The predictive value of short-term changes in hemoglobin concentration in patients presenting with acute decompensated heart failure. 
  • The relationship between maternal anemia and umbilical cord oxygen content at delivery. 
  • The risk of acute kidney injury with co-occurrence of anemia and hypotension during cardiopulmonary bypass relative to anemia alone. 
  • The use of GTX as second-line and later chemotherapy for metastatic pancreatic cancer: a retrospective analysis. 
  • The use of haemoglobin glutamer-250 (HBOC-201) as an oxygen bridge in patients with acute anaemia associated with surgical blood loss. 
  • Three Times Weekly Dosing of Daprodustat versus Conventional Epoetin for Treatment of Anemia in Hemodialysis Patients: ASCEND-TD: A Phase 3 Randomized, Double-Blind, Noninferiority Trial. 
  • Too much, too little, or just right?: untangling endogenous erythropoietin in heart failure. 
  • Transferrin is a major determinant of hepcidin expression in hypotransferrinemic mice. 
  • Transferrin receptor is necessary for development of erythrocytes and the nervous system. 
  • Transfusion practice and outcomes in non-ST-segment elevation acute coronary syndromes. 
  • Trastuzumab emtansine versus capecitabine plus lapatinib in patients with previously treated HER2-positive advanced breast cancer (EMILIA): a descriptive analysis of final overall survival results from a randomised, open-label, phase 3 trial. 
  • Trastuzumab plus vinorelbine or taxane chemotherapy for HER2-overexpressing metastatic breast cancer: the trastuzumab and vinorelbine or taxane study. 
  • Treatment of anemia with darbepoetin alfa in systolic heart failure. 
  • Treatment patterns and outcomes in the management of anaemia in cancer patients in Europe: findings from the Anaemia Cancer Treatment (ACT) study. 
  • Treatment strategies for myeloid growth factors and intravenous iron: when, what, and how? 
  • Treatment through a preoperative anemia clinic is associated with a reduction in perioperative red blood cell transfusion in patients undergoing orthopedic and gynecologic surgery. 
  • Trends and Inpatient Outcomes of Primary Atrial Fibrillation Hospitalizations with Underlying Iron Deficiency Anemia: An Analysis of The National Inpatient Sample Database from 2004 -2018. 
  • Trends in anemia care in older patients approaching end-stage renal disease in the United States (1995-2010). 
  • Trends in anemia management in US hemodialysis patients 2004-2010. 
  • Tumor oxygenation: a matter of supply and demand. 
  • Tumor-induced erythroid precursor-differentiated myeloid cells mediate immunosuppression and curtail anti-PD-1/PD-L1 treatment efficacy. 
  • Type II congenital dyserythropoietic anemia. 
  • Umbralisib, a novel PI3Kδ and casein kinase-1ε inhibitor, in relapsed or refractory chronic lymphocytic leukaemia and lymphoma: an open-label, phase 1, dose-escalation, first-in-human study. 
  • Unexplained anemia of aging: Etiology, health consequences, and diagnostic criteria. 
  • Use of erythropoietin in cancer patients: assessment of oncologists' practice patterns in the United States and other countries. 
  • Usefulness of anemia as a predictor of death and rehospitalization in patients with decompensated heart failure. 
  • Using capsule endoscopy to identify GI tract lesions in cirrhotic patients with portal hypertension and chronic anemia. 
  • Utilization of darbepoetin alfa in relation to cancer patients' hemoglobin levels. 
  • Visual improvement despite radiologically stable disease after treatment with carboplatin in children with progressive low-grade optic/thalamic gliomas. 
  • Visual loss after spine surgery: a population-based study. 
  • Vitamin D deficiency and anemia in early chronic kidney disease. 
  • What Should Define Preoperative Anemia in Primary THA? 
  • When Should Complete Blood Count Tests Be Performed in Primary Total Hip Arthroplasty Patients? 
  • [Association between anemia and 3-year all-cause mortality among oldest old people in longevity areas in China]. 
  • [Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes]. 
  • [Renal fibrosis and anemia]. 
  • rHuEPO and improved treatment outcomes: potential modes of action. 
• 

  Keywords of People

  • Bennett, Vann, George Barth Geller Distinguished Professor of Molecular Biology, Duke Cancer Institute
  • Berchuck, Andrew, James M. Ingram Distinguished Professor of Gynecologic Oncology, Obstetrics and Gynecology, Gynecologic Oncology
  • Blitz, Jeanna, Associate Professor of Anesthesiology, Anesthesiology, General, Vascular, High Risk Transplant & Critical Care
  • Jowell, Paul Simon, Professor of Medicine, Medicine, Gastroenterology
  • Mentz, Robert John, Associate Professor of Medicine, Medicine, Cardiology
  • Patel, Uptal Dinesh, Adjunct Professor in the Department of Medicine, Medicine, Nephrology